SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-291815
Filing Date
2023-12-08
Accepted
2023-12-08 17:28:55
Documents
2
Group Members
ESSEX WOODLANDS FUND IX-GP, L.P.ESSEX WOODLANDS IX, LLCEW HEALTHCARE PARTNERS-A L.P.MARTIN P. SUTTERPETRI VAINIOR. SCOTT BARRYRONALD EASTMANSTEVE WIGGINS

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d884875dsc13da.htm SC 13D/A 179604
2 EX-99.1 d884875dex991.htm EX-99.1 13935
  Complete submission text file 0001193125-23-291815.txt   195637
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81613 | Film No.: 231476435
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380
Business Address 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380 281-364-1555
EW Healthcare Partners, L.P. (Filed by) CIK: 0001612343 (see all company filings)

IRS No.: 471044766 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A